Related Experiment Video
Updated: Jun 7, 2025

15:00
The Impact of Motor Task Conditions on Goal-Directed Arm Reaching Kinematics and Trunk Compensation in Chronic Stroke Survivors
Published on: May 2, 2021
3.5K
Sheffield Adaptive Patterned Electrical Stimulation (SHAPES) Therapy for Post Stroke Arm spasticity: study protocol
Ali Ali1,2, Avril D McCarthy3,4, Mark Reeves3
1Sheffield Institute of Translational Neurosciences, University of Sheffield, Sheffield, UK. ali.ali@sheffield.ac.uk.
BMC Neurology
|November 10, 2024
Summary
This study compares Sheffield Adaptive Patterned Electrical Stimulation (SHAPES) to TENS and standard care for post-stroke elbow spasticity. SHAPES may offer a cost-effective, self-administered management option for spasticity.
Area of Science:
- Neurology
- Rehabilitation Medicine
- Biomedical Engineering
Background:
- Post-stroke elbow spasticity (PSES) significantly impairs functional recovery and quality of life in over a third of stroke survivors.
- Current treatments like drugs and botulinum toxin have limitations including side effects, high cost, and limited long-term efficacy.
- Conventional electrical stimulation therapies can be limited by long-term habituation.
Purpose of the Study:
- To investigate the efficacy of Sheffield Adaptive Patterned Electrical Stimulation (SHAPES) in reducing PSES.
- To compare SHAPES against transcutaneous electrical stimulation (TENS) and standard care.
- To evaluate the impact of SHAPES on arm motor function and quality of life.
Main Methods:
- A randomized controlled trial involving 297 participants with PSES, allocated 1:1:1 to standard care, TENS, or SHAPES.
- Interventions delivered daily for 60 minutes over 6 weeks using a specialized electrical stimulation sleeve.
- Outcome measures assessed at baseline, end of treatment, and at 6, 12, and 24 weeks post-treatment, including the Numerical Rating Scale for PSES, arm function, and quality of life.
Main Results:
- Efficacy determined by the proportion of participants achieving a meaningful improvement (18%) in the 7-day NRS-S for PSES.
- Comparison of improvement rates between SHAPES, TENS, and standard care groups.
- Assessment of secondary outcomes including arm motor function and quality of life, alongside a health economic evaluation.
Conclusions:
- The SHAPES trial will provide crucial data to inform the management of post-stroke elbow spasticity.
- SHAPES presents a potentially low-cost, self-administered, and repeatable intervention for spasticity management.
- The study will offer essential evidence on the efficacy of TENS for spasticity, addressing a gap in current clinical practice.

